BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9095361)

  • 1. Efficient functionalization of 2',5'-oligoadenylates with sulfur.
    Lesiak K; Torrence PF
    Bioconjug Chem; 1997; 8(2):199-203. PubMed ID: 9095361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.
    Imai J; Lesiak K; Johnston MI; Torrence PF
    Nucleic Acids Symp Ser; 1982; (11):97-100. PubMed ID: 7183979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical synthesis and biological activities of partially inosine-substituted 2',5'-oligoadenylates: functional discrimination of three adenine amino groups on 2-5A for the binding to and activation of 2-5A-dependent endonuclease.
    Imai J; Lesiak K; Torrence PF
    Nucleic Acids Symp Ser; 1984; (15):81-4. PubMed ID: 6522297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
    Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH
    J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative.
    Latham KE; Cosenza S; Reichenbach NL; Mordechai E; Adelson ME; Kon N; Horvath SE; Charubala R; Mikhailov SN; Pfeiderer W; Suhadolnik RJ
    Oncogene; 1996 Feb; 12(4):827-37. PubMed ID: 8632905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates.
    Pav O; Protivinska E; Pressova M; Collinsova M; Jiracek J; Snasel J; Masojidkova M; Budesinsky M; Rosenberg I
    J Med Chem; 2006 Jun; 49(13):3955-62. PubMed ID: 16789752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
    Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
    Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new and potent 2-5A analogue which does not require a 5'-polyphosphate to activate mouse L-cell RNase L.
    Torrence PF; Brozda D; Alster DK; Pabuccuoglu A; Lesiak K
    Antiviral Res; 1992 Jun; 18(3-4):275-89. PubMed ID: 1416909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization of adenosin-5'-O-ylmethylphosphonate, an isopolar AMP analogue: evaluation of the route to short oligoadenylates.
    Pressová M; Budesínský M; Kosiová I; Kopecký V; Cvacka J; Kasicka V; Simák O; Tocík Z; Rosenberg I
    Biopolymers; 2010 Mar; 93(3):277-89. PubMed ID: 19844977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.
    Kitade Y; Nakata Y; Hirota K; Maki Y; Pabuccuoglu A; Torrence PF
    Nucleic Acids Res; 1991 Aug; 19(15):4103-8. PubMed ID: 1714563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-specific 2'5'-oligonucleotides in the molecular dissection of the biological activity of 2-5A.
    Torrence PF; Imai J; Jamoulle JC; Wong A; Lesiak K
    Prog Clin Biol Res; 1985; 202():75-80. PubMed ID: 3832077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endowing RNase H-inactive antisense with catalytic activity: 2-5A-morphants.
    Zhou L; Civitello ER; Gupta N; Silverman RH; Molinaro RJ; Anderson DE; Torrence PF
    Bioconjug Chem; 2005; 16(2):383-90. PubMed ID: 15769093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2',5'-Oligoadenylate:antisense chimeras--synthesis and properties.
    Lesiak K; Khamnei S; Torrence PF
    Bioconjug Chem; 1993; 4(6):467-72. PubMed ID: 8305516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomerization aiming at phosphonate analogues of oligoadenylates.
    Pressová M; Liboska R; Budesínský M; Králíková S; Kavenová I; Rosenberg I
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1049-52. PubMed ID: 14565341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification potentiates the biological activities of 2-5A and its congeners.
    Imai J; Johnston MI; Torrence PF
    J Biol Chem; 1982 Nov; 257(21):12739-45. PubMed ID: 7130175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.